SHORT_NAME	LONG_NAME	ABSTRACT	CANCER_SITE	PATIENT_ID_NAME	INTEGRATED	OVERALL_ACCESS	SCHEMA_NAME	USE_IN_GUI	CONTENT_TYPES	SHOW_CONTENT_IN_GUI
BRC_ZHANG_2009_01	The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy	Classification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature.  <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12093">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12093</a>	BREAST	Sample iid	1	PUBLIC	BRC_ZHANG_2009_01	1	CLINIC, MICROARRAY	1, 1
